© 2023 BioMarin. All rights reserved.

BioMarin to Participate in Four Upcoming Virtual Investor Conferences
- 2021 SVB Leerink Global Healthcare Conference on February 26 at 11:20am ET
- Cowen 41st Annual Health Care Conference on March 4 at 12:50pm ET
- Barclays Global Healthcare Conference on March 9 at 2:25pm ET
- 10th Annual J.P. Morgan Napa Valley Forum on March 29 at 12:00pm ET
Feb 24, 2021

SAN RAFAEL, Calif., Feb. 24, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.





Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558 

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.